arBtrage CAPITALIZING MARKETS — checking… Sign in Sign up
Calendar /

Atea Pharmaceuticals, Inc.

AVIR Health Care Biotechnology: Pharmaceutical Preparations
$4.04
▼ -1.0% Today
as of Oct 23, 16:46 ET
Last 30 days -24.06% Sep 14 → Oct 23
$3.91 $4.38 $4.84 $5.30 $5.77 Sep 14 Sep 22 Sep 30 Oct 07 Oct 15 Oct 23
Open
$4.03
High
$4.11
Low
$3.93
Volume
$245,442
Avg Vol
$391,400
Mkt Cap
$409M
P/E (TTM)
—
Beta
—
52w High
$6.45
52w Low
$2.87
Div Yield
—
Shares Out
$80M

Recent Press Releases & News last 60 days · 1 item

Sep 8 · 11:00 PR GlobeNewswire
Atea Pharmaceuticals to Present at the Morgan Stanley 24th Annual Global Healthcare Conference

AVIR earnings at a glance

The options market is pricing a move of about ±15.6% after the report, a range of roughly $3.41 to $4.67 from today's $4.04. Over its last 2 reports the stock rose the next day 2 times and fell 0, moving ±5.2% on average; after the most recent report on May 12, 2026 it moved +1.7%. That means options currently expect more movement than AVIR has typically delivered. AVIR beat the consensus EPS estimate in 3 of its last 4 reported quarters. Implied volatility is currently 100%. The share price of $4.04 sits in the middle of its 52-week range.

More Health Care stocks · All stocks · Earnings calendar

Overview

52-week range
$2.87
$6.45
33% of range
Avg surprise (last 4)
+5.7%
Avg reaction (last 2)
+5.2%
100% positive
Latest IV / EM
100%
EM ±15.6% · $5 · Oct 16

Earnings trends

EPS — actual vs estimate Actual Estimate
$-0.75$-0.65$-0.55$-0.44$-0.34 Actual $-0.43Actual $-0.34Actual $-0.40Actual $-0.75Actual $-0.48Actual $-0.37Actual $-0.40Est $-0.56Actual $-0.44Est $-0.46Actual $-0.53Est $-0.46Actual $-0.57Est $-0.60Actual $-0.41 MarJunSepMarJunSepMar/2025Jun/2025Sep/2025Mar/2026Jun
Revenue vs Net Income Revenue Net income
$-45M$-42M$-39M$-36M$-33M Sep 24Mar 25Jun 25Sep 25Mar 26Jun 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Tue Jun 30, 2026Jun 2026 $-0.41 — — — — financials
Tue May 12, 2026Mar/2026 $-0.57 $-0.60 +5.0% -42.5% +1.7% earnings
Wed Nov 12, 2025Sep/2025 $-0.53 $-0.46 -15.2% — — earnings
Thu Aug 7, 2025Jun/2025 $-0.44 $-0.46 +4.3% — — earnings
Mon May 12, 2025Mar/2025 $-0.40 $-0.56 +28.6% — +8.8% earnings
Mon Sep 30, 2024Sep 2024 $-0.37 — — — — financials
Sun Jun 30, 2024Jun 2024 $-0.48 — — — — financials
Sun Mar 31, 2024Mar 2024 $-0.75 — — — — financials
Sat Sep 30, 2023Sep 2023 $-0.40 — — — — financials
Fri Jun 30, 2023Jun 2023 $-0.34 — — — — financials
Fri Mar 31, 2023Mar 2023 $-0.43 — — — — financials

Financials

Income statement (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue————————
Cost of revenue————————
Gross profit————————
Operating income$-35M$-48M—$-46M$-41M$-39M—$-37M
Net income$-33M$-45M—$-42M$-37M$-34M—$-31M
EPS (diluted)$-0.41$-0.57—$-0.53$-0.44$-0.40—$-0.37

Balance sheet (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Cash & equivalents$77M$79M$96M$77M$88M$119M$65M$98M
Inventory————————
Total current assets$229M$263M$311M$336M$386M$434M$462M$487M
Total assets$232M$267M$315M$343M$392M$440M$465M$491M
Long-term debt————————
Total liabilities———$27M$27M$29M$26M$32M
Total equity$204M$234M$275M$316M$364M$411M$439M$459M

Implied volatility — last 90 days

37%475%912%1350%1788% Jun 07 — IV 289% · EM ±40.0%Jun 08 — IV 272% · EM ±35.9%Jun 16 — IV 1789% · EM ±105.6%Jun 17 — IV 1189% · EM ±49.7%Jun 19 — IV 101% · EM ±22.4%Jun 22 — IV 65% · EM ±13.7%Jun 23 — IV 60% · EM ±12.3%Jun 24 — IV 50% · EM ±10.0%Jun 25 — IV 53% · EM ±10.3%Jun 26 — IV 47% · EM ±8.9%Jun 29 — IV 113% · EM ±20.1%Jun 30 — IV 37% · EM ±6.5%Jul 01 — IV 69% · EM ±11.5%Jul 02 — IV 56% · EM ±9.0%Jul 03 — IV 58% · EM ±9.0%Jul 07 — IV 132% · EM ±17.4%Jul 08 — IV 133% · EM ±16.6%Jul 09 — IV 233% · EM ±27.5%Jul 10 — IV 100% · EM ±11.0%Jul 13 — IV 253% · EM ±21.1%Jul 14 — IV 338% · EM ±24.5%Jul 15 — IV 366% · EM ±21.6%Jul 16 — IV 482% · EM ±20.1%Jul 20 — IV 115% · EM ±27.2%Jul 21 — IV 159% · EM ±37.0%Jul 22 — IV 250% · EM ±57.2%Jul 23 — IV 197% · EM ±44.2%Jul 24 — IV 143% · EM ±31.6%Jul 27 — IV 139% · EM ±29.0%Jul 28 — IV 200% · EM ±41.0%Jul 29 — IV 200% · EM ±40.0%Jul 30 — IV 116% · EM ±22.7%Jul 31 — IV 128% · EM ±24.5%Aug 04 — IV 136% · EM ±23.4%Aug 05 — IV 132% · EM ±22.1%Aug 07 — IV 91% · EM ±14.3%Aug 10 — IV 129% · EM ±17.9%Aug 11 — IV 82% · EM ±10.9%Aug 12 — IV 142% · EM ±17.8%Aug 13 — IV 117% · EM ±13.8%Aug 17 — IV 183% · EM ±15.3%Aug 19 — IV 409% · EM ±24.1%Aug 24 — IV 98% · EM ±20.4%Aug 25 — IV 83% · EM ±17.0%Aug 26 — IV 88% · EM ±17.7%Aug 27 — IV 145% · EM ±28.4%Aug 28 — IV 132% · EM ±25.2%Aug 31 — IV 227% · EM ±40.2%Sep 01 — IV 132% · EM ±22.8%Sep 02 — IV 158% · EM ±26.4%Sep 03 — IV 175% · EM ±28.4%Sep 04 — IV 192% · EM ±30.0%Sep 07 — IV 217% · EM ±30.0%Sep 08 — IV 247% · EM ±32.6%Sep 09 — IV 189% · EM ±23.7%Sep 11 — IV 187% · EM ±20.7%Sep 14 — IV 191% · EM ±16.0%Sep 15 — IV 238% · EM ±17.2%Sep 17 — IV 319% · EM ±13.3%Sep 21 — IV 115% · EM ±23.9%Sep 22 — IV 100% · EM ±20.4%Sep 23 — IV 128% · EM ±25.6%Sep 24 — IV 133% · EM ±26.1%Sep 25 — IV 111% · EM ±21.3%Sep 28 — IV 109% · EM ±19.2%Sep 30 — IV 167% · EM ±27.8%Oct 01 — IV 103% · EM ±16.7%Oct 02 — IV 100% · EM ±15.6%

Sector peers

TTRX
Turn Therapeutics Inc.
$396M $10.28+1.3%
RLMD
Relmada Therapeutics, Inc.
$390M $3.27+1.9%
DMAC
DiaMedica Therapeutics Inc.
$450M $8.72+0.3%
EBS
Emergent BioSolutions Inc.
$363M $6.23+0.5%
EVMN
Evommune, Inc.
$472M $5.10-1.4%
BNTC
Benitec Biopharma Inc.
$334M $8.65+1.8%

AVIR earnings FAQ

What is AVIR's expected move for earnings?

Options currently price a move of about ±15.6%, or $0.63 per share either way from $4.04.

How does AVIR stock usually react to earnings?

Across the last 2 reports the average next-day move was ±5.2%, up 2 times and down 0 times.

What is AVIR's implied volatility?

AVIR's at-the-money implied volatility is about 100% based on the latest options snapshot.

View on Nasdaq ↗
🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.
Sign up free → Sign in